• α-Amanitin in Transcriptional Regulation: Applied Workflows

  2026-05-09

  α-Amanitin empowers researchers to dissect RNA polymerase II-driven transcription with unparalleled specificity, enabling advanced gene expression pathway analysis and oocyte developmental studies. This guide translates recent chromatin reorganization breakthroughs and practical assay workflows into actionable protocols, maximizing reproducibility and data clarity.

• Biotin-tyramide: Redefining Proximity Labeling for Translati

  2026-05-09

  This article explores the mechanistic power and translational impact of Biotin-tyramide, spotlighting its role in enzyme-mediated signal amplification for advanced spatial proteomics and proximity labeling. Leveraging recent findings on RAB GTPase interactomes, we provide strategic, evidence-driven guidance for researchers aiming to unlock new biological insights with precision and reproducibility.

• Secreted METTL9 Methyltransferase Restricts Candida in the G

  2026-05-08

  Bao et al. identify secreted METTL9 as a cross-kingdom antifungal defense mechanism in the intestinal epithelium. By methylating the fungal zincophore PRA1, METTL9 limits Candida albicans colonization and dissemination, suggesting new avenues for antifungal research beyond conventional drug approaches.

• Sulfo-Cy3 Azide in Neurodevelopment: Quantitative Fluorescen

  2026-05-07

  Explore how Sulfo-Cy3 azide, a premier bioconjugation reagent, enables high-fidelity Click Chemistry fluorescent labeling for quantitative neurodevelopmental mapping. Discover advanced assay design, protocol parameters, and unique insights from recent claustrum research.

• NADH in Mitochondrial Electron Transport Chain Research

  2026-05-07

  Leverage reduced nicotinamide adenine dinucleotide (NADH) for advanced mitochondrial electron transport chain research and disease modeling. Discover protocol enhancements, troubleshooting insights, and the latest high-throughput screening innovations that set APExBIO's NADH apart for precise metabolic and redox studies.

• Catalpol Inhibits Liver Fibrosis via EphA2/FAK/Src and Glyco

  2026-05-06

  The referenced study demonstrates that catalpol effectively ameliorates hepatic fibrosis by directly inhibiting aerobic glycolysis in hepatic stellate cells through the EphA2/FAK/Src signaling axis. This mechanistic insight advances the understanding of metabolic reprogramming in liver fibrosis and clarifies potential molecular targets for anti-fibrotic therapy.

• Oral Gepotidacin for Gonorrhoea: Phase 3 Non-Inferiority Out

  2026-05-06

  The EAGLE-1 phase 3 trial demonstrates that oral gepotidacin is non-inferior to standard dual therapy for uncomplicated urogenital gonorrhoea, offering a novel oral treatment option. These findings have significant implications for antimicrobial stewardship and the development of alternative regimens amid rising resistance.

• Flavopiridol (A3417): Integrative Insights on CDK Inhibition

  2026-05-05

  Explore how Flavopiridol, a potent pan-CDK inhibitor, uniquely interfaces with endoplasmic reticulum stress pathways to drive cell cycle arrest and apoptosis in cancer research. Uncover advanced protocol guidance and actionable insights not covered in standard guides.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Workflow Gui

  2026-05-05

  E. coli Uracil-DNA Glycosylase (UDG) is a recombinant DNA repair enzyme for excising uracil from DNA, thereby reducing PCR product contamination and improving amplification fidelity. It should only be used in research workflows targeting DNA, not for RNA or clinical/diagnostic purposes.

• MRT68921: Precision ULK1 Kinase Inhibitor for Autophagy Rese

  2026-05-04

  MRT68921 empowers researchers with nanomolar, dual ULK1/2 kinase inhibition for dissecting autophagy signaling. Its precision and reproducibility outperform legacy approaches, enabling robust blockade of ATG13 phosphorylation and LC3 flux in preclinical workflows.

• Structural Basis of Tiamulin Action and Resistance in Riboso

  2026-05-04

  This study elucidates the molecular interactions of Tiamulin, a pleuromutilin antibiotic, with the 50S ribosomal subunit and details key resistance mechanisms via mutations in ribosomal protein L3 and 23S rRNA. Findings provide a framework for rational design of next-generation pleuromutilin derivatives and highlight implications for veterinary antibiotic stewardship.

• PAD4-IN-2 TFA: Protocols & Precision for Tumor Microenvironm

  2026-05-03

  PAD4-IN-2 TFA (Compound 5i TFA) empowers cancer researchers with a highly selective, tumor-targeted approach to PAD4 inhibition—enabling precise modulation of the tumor immune microenvironment and robust suppression of tumor growth and metastasis. This guide translates recent mechanistic breakthroughs into actionable workflows, troubleshooting strategies, and advanced applications, maximizing research outcomes with minimal toxicity.

• Protease Inhibitor Cocktail EDTA-Free: Workflow Precision &

  2026-05-02

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) delivers robust, phosphorylation-compatible protection during protein extraction, enabling advanced studies of post-translational modifications and signaling. Its EDTA-free formulation ensures compatibility with divalent cation-dependent assays, redefining experimental flexibility and reliability.

• SIS3 and Smad3 Inhibition: Rethinking Fibrosis and OA Models

  2026-05-02

  This thought-leadership article dissects the mechanistic and translational landscape of Smad3 inhibition using SIS3, with a focus on fibrosis and osteoarthritis research. Integrating cutting-edge mechanistic insights and actionable experimental design guidance, the article anchors its discussion in recent peer-reviewed findings while offering a strategic roadmap for translational investigators.

• Munc18c–Syntaxin4 Interaction Drives Tumor Cell Invasion Mec

  2026-05-01

  This study uncovers how the interaction between Munc18c and syntaxin4 (Stx4) regulates the formation of invadopodia and enables tumor cells to invade the extracellular matrix. By delineating the molecular trafficking events underpinning metastatic potential, the research provides a mechanistic basis for targeting SNARE-mediated pathways in cancer invasion models.

455 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page